MHH Logo

Year 2007

  1. Rakesh Bakshi INDIA
    supervisor: PD Dr. H. Wedemeyer, Gastroenterology, Hepatology & Endocrinology, OE 6810,  
    project: Role of heterologous immunity for natural resistance to HCV infection

    Final exam June 2011, University of Alabama, Birmingham, USA; from 2016 scientist I, Microbiology, University of Alabama

  2. Vijay Kumar Chennupati INDIA
    supervisor: Dr. Prinz, Immunology, OE 5240,   
    project:  gd T lymphocyte migration, homing and site-specific function

    Final exam November 2010; Ludwig Institute for Cancer Research, Lausanne, Switzerland
  3. Sheetal Chettiar INDIA
    supervisor: Dr. Tamura-Niemann, Physiological Chemistry, OE 4310,    
    project: Characterization of the PEST domain of Fms interacting protein/FMIP and DNA damage signaling

    Final exam November 2011. lecturer, University of Kerala, India

  4. Jan Larmann  ( GERMANY  
    supervisor: Prof. Dr. Theilmeier, Anaestesiology, OE 8050,   
    project: Afterload-induced changes in myocardial transcription driven by thrombomodulin’s lectin-like domain

    Final exam November 2010; Anaestesiology, MHH; now Consultant ("Oberarzt"), University Hospital Heidelberg

  5. Sadaf Kasraie IRAN
    supervisor: Prof. Dr. Werfel, Dermatology, OE 6600,  
    project: Dysregulation of innate and adaptive immunity in patients with atopic dermatitis: Impact of Toll-like receptors and β-defensins

    Final exam November 2010; scientist and scientific project manager, Global Preclinical R&D, Global Drug Discovery, Grünenthal Pharma GmbH, Aachen, Germany; from 2014 Evotec, drug discovery in Inflammation, Hamburg; from 2017 senior project manager, The Aptuit Center for Drug Discovery & Development, Verona, Italy

  6. Katja Crull (KochrübeGERMANY
    supervisor: Prof. Dr. Weiss, Helmholtz Center for Infection Research, Braunschweig; siegfried.weiss@helmholtz-hzi.d
    project:  Identification of tumour-specific promoters of E. coli NISSLE

    Final exam June 2011; Wehrwissenschaftliches Institut, Zentrallabor, Munster

  7. Daniel Kotlarz  GERMANY
    supervisor: Prof. Dr. Klein, Pediatric Hematology and Oncology, OE 6780, (now Munich)
    project: The role of the cellular adaptor protein p14 in hematopoiesis and leukemia.

    Final exam November 2014; Klinikum d. Universität München, Kinder- und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
  8. Jayendra Kumar Krishnaswamy INDIA
    supervisor:  Prof. Dr. Behrens, Clinical Immunology, OE 6830,   
    project: Antigenic targeting of dendritic cell subsets for tolerance induction to inhaled antigens

    Final exam November 2011; Yale University School of Medicine, USA; now Senior Research Bioscientist, AstraZeneca, RIA iMED, Gothenburg, Sweden

  9. Subhashree Mahapatra INDIA
    supervisor: Dr. Dittrich,  SFB 587, OE 9431,
    project:  Polysensitization & skin lung interplay in a mouse model of allergic skin inflammation

    Final exam November 2012; Advanced research scientist, L'Oreal, Paris; from 2016 Business Development Manager, Lubrizol, Barcelona

  10. Ankita Minhas INDIA
    supervisor: Prof. Dr. Klein, Pediatric Hematology and Oncology, OE 6780, 
    project: The use of morpholino based knockdown gene technology as well as genetic studies  to determine the function of HAX1 in zebrafish

    Final exam November 2011; project manager, VPM GmbH, Hannover; from 2014 Project Manager II with a global CRO Inc. Research LLC, San Diego, USA for which she relocated to Munich in 2016

  11. Susann Hartung (nee Müller) GERMANY
    supervisor: Dr. Martin, LEBAO, OE 6217,
    project: Identification of cardiogenic factors in a Rhesus monkey embryonic stem cell model

    Final exam November 2012; LEBAO MHH; from September 2013 Babypause; University Hospital Jena; now Infections in Hematology and Oncology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), Jena

  12. Mudita Pincha INDIA
    supervisor: PD Dr. Stripecke, Hematology and Oncology, OE 6860,  
    project: Lentivirus programmed dendritic cells for immunotherapy of melanoma

    Final exam November 2011, German Cancer Research Center (DKFZ), Heidelberg; from 2016 Roche Innovation Center, Zürich, Switzerland

  13. Thanaseelan Pushpanathan MALAYSIA  
    supervisor: Dr. Ehlers/Dr. Reinhardt, Pediatric Hematology and Oncology, OE 6780,
    project: Expression of the G-CSF receptor isoform IV and consecutive changes in the intracellular signal transduction in childhood acute myeloid leukemia

  14. Harald Schütt ( GERMANY
    superrvisor: Prof. Dr. Schieffer, Cardiology, OE 6880,    
    project: Investigation of cytokine signalling mechanisms in the course of atherosclerosis

    Final exam November 2010; Cardiology, MHH; from 2013 Cardiology, University Clinics Marburg
  15. Adrian Schwarzer ( GERMANY
    supervisor: Prof. Dr. Baum, Experimental Hematology, OE 6960,
    project: 1.Molecular characterization of mouse models of leukemia; 2.Mechanisms of induction of immunologic tolerance by leukemic cells; 3.Gene therapy for hematologic disorders

    Final exam November 2012; Haematology and Oncology, MHH (junior group leader) and physician

  16. Theodros Solomon Tsegaye  (MD) ETHIOPIA
    supervisor: Prof. Dr. Pöhlmann, Virology, OE 5230,
    project: HIV interaction with platelets: the role of CLEC- 2 and DC-SIGN receptors

    Final exam June 2006; Center for Disease Control and Prevention (CDC), Atlanta, USA; from 2014 US medical residency; now Internal Mecicine resident at East Carolina University, NC, USA
  17. Usriansyah INDONESIA
    supervisor: PD Dr. O. Pabst, Immunology, OE 5240,
    project: The structural, cellular and molecualr basis of intestinal tolerance

    Final exam June 2011; Dermatology, University Hospital Zuerich, Switzerland; now Market Manager, Mettler-Toledo, Urdorf, Switzerland

  18. Susanne Wolf GERMANY
    supervisor: Dr. C. Rudolph/Prof. Schlegelberger, Cell-/ Molecular Pathology, OE 5120,  
    project: Synergistic effects of histone methylation defects and oncogene activation and their contribution to the induction of chromosomal instability in leukemogenesis

    Final exam November 2011; Haematology and Oncology, MHH